Filing Flows

Filing Flows › vTv Therapeutics (VTVT) › Who owns the stock

Who owns vTv Therapeutics (VTVT) stock

44 funds reported vTv Therapeutics (VTVT) shares in their latest 13F filings, worth $63.7M in all. The largest holder is Samsara BioCapital, LLC ($11.2M). Last quarter 21 funds added to their stakes and 14 cut them.

Largest holders of VTVT (13F)Largest holders of VTVT (13F)Samsara BioCapital, LLC$11.2MMillennium Management LLC$10.2MFMR LLC$9.8MSiren, L.L.C.$6.1MBaker Bros. Advisors LP$5.6MVanguard Capital Management LLC$3.6MVanguard Group$3.3MTrails Edge Capital Partners, LP$3.2MAisling Capital Management LP$1.9MMarshall Wace, LLP$1.5M

Largest holders (13F)

FundSharesValueChangeQuarter
Samsara BioCapital, LLC298,496$11.2Munchanged2026-06-30
Millennium Management LLC269,874$10.2Mincrease2026-06-30
FMR LLC260,391$9.8Munchanged2026-06-30
Siren, L.L.C.163,000$6.1Munchanged2026-06-30
Baker Bros. Advisors LP148,314$5.6Munchanged2026-06-30
Vanguard Capital Management LLC94,463$3.6Mdecrease2026-06-30
Vanguard Group83,400$3.3Mincrease2025-12-31
Trails Edge Capital Partners, LP85,192$3.2Mdecrease2026-06-30
Aisling Capital Management LP50,000$1.9Mnew2026-06-30
Marshall Wace, LLP39,560$1.5Mincrease2026-06-30
Geode Capital Management, LLC32,470$1.2Mdecrease2026-06-30
Renaissance Technologies LLC17,454$657Knew2026-06-30
Vanguard Fiduciary Trust16,239$611Kincrease2026-06-30
BlackRock14,731$555Kincrease2026-06-30
Jane Street Group, LLC13,703$516Knew2026-06-30

vTv Therapeutics' latest quarter

vTv Therapeutics, Q1 2026: revenue $36.8M, operating margin 63.1%, net earnings $24.1M, operating cash flow $9.2M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most VTVT stock?

By the latest 13F filings: Samsara BioCapital, LLC ($11.2M); Millennium Management LLC ($10.2M); FMR LLC ($9.8M); Siren, L.L.C. ($6.1M); Baker Bros. Advisors LP ($5.6M).

What is the short interest in VTVT?

143,400 shares were sold short at the 2026-10-15 settlement, -8.52% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.